A phase-II, randomized, placebo-controlled trial of simvastatin in generalized vitiligo Principle Investigator: John E. Harris, MD, PhD Study Location: UMass Memorial Medical Center in Worcester, MA
Clinuvel Pharmaceuticals Limited today announced that the US Food and Drug Administration (FDA) has allowed the company to proceed under its current Investigational New Drug to conduct a pilot Phase II clinical trial of its drug afamelanotide (known as SCENESSE®) in patients diagnosed with nonsegmental vitiligo.
Customer Reviews
-
I have been using this Vitiligo Cover Lotion for 6 months. I have eczema on my body and white patches [vitiligo] on my face. The white patches disappear whenever I put the lotion on. Whoever has vitiligo should try this.*
Nondita R.
-
Hope you are well. Thank you for the lotion it really is a great camouflage lotion!*
Rajvir
-
Thank you so much for developing this amazing product. I can now enjoy my summer months in shorts and short sleeve shirts with confidence. You have in me a customer for life!*
Monica
-
Thank you for your e-mail. It’s very rare to receive this level of service anywhere so it’s been a pleasure to order from you! You’re a star!*
James
-
Thanks Nathalie, your product continues to be my Godsend.*
Julia
-
Nathalie,
Been using your product for over a year now and I’m incredibly thankful for it.*Anonymous
Hi, I’m Nathalie. After spending a lot of money trying different products to cover my vitiligo and never finding a good solution, I worked with a chemist to develop Vitiligo Cover lotion. It’s simple to use, blends away the vitiligo areas, and is waterproof.
Results may vary from person to person